MONDAY, Sept. 25, 2023 — For patients infected with omicron at high risk for progression to severe disease, treatment with nirmatrelvir or molnupiravir is associated with reductions in mortality and hospitalization, according to a study published…Original Article
Nirmatrelvir, Molnupiravir Use Lowers Risks for Omicron-Infected
MONDAY, Sept. 25, 2023 — For patients infected with omicron at high risk for progression to severe disease, treatment with nirmatrelvir or molnupiravir is associated with reductions in mortality and hospitalization, according to a study published…
